Related Experiment Videos
Intrapleural streptokinase for the treatment of childhood empyema
Man-Yau Ho1, Hsiang-Yin Chen, Yu-Hsuan Yen
1Department of Pediatrics, Taipei Medical University - Wanfang Hospital, Taipei, Taiwan.
Insights
Intrapleural streptokinase instillation safely improved pediatric empyema drainage, reducing treatment duration and need for surgery. This fibrinolytic therapy offers a promising adjunctive treatment for childhood empyema.
Area of Science:
- Pediatric Pulmonology
- Thoracic Surgery
- Infectious Diseases
Background:
- Empyema is a severe pneumonia complication in children, often requiring invasive drainage.
- Current treatment for loculated empyema involves percutaneous catheter drainage.
- Intrapleural fibrinolytic agents can aid drainage of viscous pleural fluid.
Purpose of the Study:
- To compare streptokinase instillation with conventional chest tube drainage for pediatric empyema.
- To evaluate the efficacy and safety of streptokinase as an adjunctive therapy.
Main Methods:
- Retrospective study of 21 pediatric empyema cases (1999-2005).
- Comparison between streptokinase (SK) instillation group and conventional tube drainage (T) group.
- Data collected on drainage volume, duration, febrile course, need for surgery, and hospitalization length.
Main Results:
- The SK group showed significantly shorter drainage duration (8 vs. 16 days, p=0.02).
- Fewer patients in the SK group required video-assisted thoracoscopic surgery (VATS) compared to the T group (0 vs. 5).
- Hospitalization was shorter in the SK group (21.5 vs. 24 days).
Conclusions:
- Intrapleural streptokinase is a safe adjunctive therapy for pediatric empyema, facilitating drainage.
- Streptokinase instillation may reduce the need for VATS and shorten hospital stays.
- Further research is needed to compare fibrinolytic agents with VATS as primary treatment.
Background:
Pleuritis with empyema is a serious complication of bacterial pneumonia, which often causes substantial morbidity and mortality among pediatric patients. Currently percutaneous catheter drainage is the mainstay therapy for loculated empyema. Intrapleural instillation of streptokinase, urokinase, and recombinant tissue plasminogen activator has been reported to facilitate the drainage of viscous fluid and fibrinous debris or multiple loculations from the pleural space of such patients.
Methods:
In this study, we compared with the treatments of pleural empyema by instillation of streptokinase through the chest tube and using the conventional chest tube drainage alone.
Results:
We collected 21 cases from 1999 through 2005. The results of the study showed that streptokinase (SK) group patients revealed a larger volume of drainage in the beginning days of the instillation and required fewer days of drainage than tube drainage (T) group patients [8 (4.5 - 10) days vs. 16 (5.8 - 20.3) days, p = 0.02]; that the SK group patients required average 2.6 instillations. The SK patients had a shorter febrile course than the T group [12.5 (9.5 - 15.5) days vs. 16 (9.5 - 22.5) days, p = 0.14]. None of the SK patients needed additional video-assisted thoracoscopic surgery (VATS) whereas 5 patients in the T group did. The length of hospitalization in the SK group was 21.5 days and the T group patients was 24 days.
Conclusions:
Intrapleural instillation of streptokinase seldom caused clinical adverse effect and appears to be a safe adjunctive therapy to facilitate the drainage of empyema in pediatric patients. Further studies with better research design to compare the fibrinolytic agent instillation and the VATS as the first step treatment of childhood empyema are needed.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Streptococcal Pharyngitis
Acute Pyelonephritis II: Diagnostic Studies and Management
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History: